Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B40d7df89a0bcfe4c71204f7e54a68fe6> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B40d7df89a0bcfe4c71204f7e54a68fe6 NCIT_P378 "NCI" @default.
- B40d7df89a0bcfe4c71204f7e54a68fe6 type Axiom @default.
- B40d7df89a0bcfe4c71204f7e54a68fe6 annotatedProperty IAO_0000115 @default.
- B40d7df89a0bcfe4c71204f7e54a68fe6 annotatedSource NCIT_C178439 @default.
- B40d7df89a0bcfe4c71204f7e54a68fe6 annotatedTarget "A preparation of T-lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the human tumor-associated antigen (TAA) mesothelin (MSLN), with potential immunomodulating and antineoplastic activities. Upon administration, the anti-MSLN CAR-T cells LCAR-M23 specifically target and kill MSLN-expressing tumor cells. Mesothelin, a cell surface glycoprotein involved in cell adhesion, is overexpressed in a variety of cancer cell types." @default.